Works matching AU Carcedo, David


Results: 15
    1

    Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 381, doi. 10.1007/s40487-025-00333-7
    By:
    • Encinas, Cristina;
    • Lozano, Virginia;
    • Hlavacek, Patrick;
    • Llinares, Julia;
    • Toribio-Castelló, Sofía;
    • Carcedo, David;
    • Asís-Montalt, Jordi;
    • Martínez-López, Joaquín
    Publication type:
    Article
    2

    Detection of genomic alterations in liquid biopsies from patients with non-small cell lung cancer using FoundationOne Liquid CDx: a cost-effectiveness analysis.

    Published in:
    Journal of Medical Economics, 2024, v. 27, n. 1, p. 1379, doi. 10.1080/13696998.2024.2413289
    By:
    • Isla, Dolores;
    • Álvarez, Rosa;
    • Arnal, María;
    • Arriola, Edurne;
    • Azkarate, Aitor;
    • Azkona, Eider;
    • García-Campelo, Rosario;
    • Garrido, Pilar;
    • Nadal, Ernest;
    • Ortega, Ana L.;
    • Carcedo, David;
    • Crespo, María;
    • Lavara, Jesús;
    • Córcoles, Fernando;
    • Bernabé, Reyes
    Publication type:
    Article
    3

    Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1.

    Published in:
    Journal of Medical Economics, 2023, v. 26, n. 1, p. 445, doi. 10.1080/13696998.2023.2188844
    By:
    • Escudero-Vilaplana, Vicente;
    • Collado-Borrell, Roberto;
    • De Castro, Javier;
    • Insa, Amelia;
    • Martínez, Alex;
    • Fernández, Elena;
    • Sullivan, Ivana;
    • Flores, Andrés;
    • Arrabal, Natalia;
    • Carcedo, David;
    • Manzaneque, Alba
    Publication type:
    Article
    4

    Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain.

    Published in:
    Journal of Medical Economics, 2021, v. 24, p. 628, doi. 10.1080/13696998.2021.1916749
    By:
    • Carcedo Rodriguez, David;
    • Artola Urain, Teresa;
    • Chinea Rodriguez, Anabelle;
    • Torres, Estefanía García;
    • González Vicent, Marta;
    • Gutiérrez García, Gonzalo;
    • Regueiro Garcíag, Alexandra;
    • Calvo Hidalgo, Marcos;
    • Villacampa, Alba
    Publication type:
    Article
    5

    Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in Spain.

    Published in:
    Journal of Medical Economics, 2021, v. 24, n. 1, p. 628, doi. 10.1080/13696998.2021.1916749
    By:
    • Carcedo Rodriguez, David;
    • Artola Urain, Teresa;
    • Chinea Rodriguez, Anabelle;
    • García Torres, Estefanía;
    • González Vicent, Marta;
    • Gutiérrez García, Gonzalo;
    • Regueiro García, Alexandra;
    • Calvo Hidalgo, Marcos;
    • Villacampa, Alba
    Publication type:
    Article
    6
    7
    8
    9

    Actionable mutational profiling in solid tumors using hybrid‐capture‐based next‐generation sequencing in a real‐world setting in Spain.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6827
    By:
    • Zazo, Sandra;
    • Pérez‐Buira, Sandra;
    • Carvajal, Nerea;
    • Plaza‐Sánchez, Jenifer;
    • Manso, Rebeca;
    • Pérez‐González, Nuria;
    • Dominguez, Carolina;
    • Prieto‐Potin, Iván;
    • Rubio, Jaime;
    • Dómine, Manuel;
    • Lozano, Virginia;
    • Mohedano, Patricia;
    • Carcedo, David;
    • Carias, Rafael;
    • Rojo, Federico
    Publication type:
    Article
    10
    11
    12
    13
    14
    15